ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 2020 project topics
Adverse Drug Reaction Genetic Marker Discovery
Identifying HLA alleles and other genetic markers associated with severe adverse drug reactions for developing pre-prescription genetic screening tests.
Pharmacogenomics and Drug Response Genetics Click to view more details →
Warfarin Dosing Algorithm Development
Developing pharmacogenomics-based warfarin dosing algorithms incorporating CYP2C9 and VKORC1 variants for improved anticoagulation management.
Pharmacogenomics and Drug Response Genetics Click to view more details →
Pharmacogenomic Testing Platform for Personalized Medication Selection
A SaaS-based clinical decision support system that analyzes patient genetic profiles to recommend optimal drug selections and dosages before prescription. This platform reduces adverse drug events and hospitalizations, enabling healthcare providers to offer premium precision medicine services with improved patient outcomes and reduced litigation risk.
Pharmacogenomics and Drug Response Genetics Click to view more details →
HLA Allele Typing Service for Drug Hypersensitivity Prediction
An automated genetic testing service that identifies HLA variants associated with severe drug hypersensitivity reactions including abacavir, allopurinol, and carbamazepine toxicity. Pharmaceutical companies and hospitals license this service to prevent serious adverse events, reduce patient safety liability, and differentiate their treatment protocols in competitive markets.
Pharmacogenomics and Drug Response Genetics Click to view more details →
Genetic Biomarker Stratification Tool for Oncology Drug Response
A bioinformatics platform that identifies somatic and germline genetic mutations predicting patient response to targeted cancer therapies and immunotherapies. This tool enables pharmaceutical manufacturers to support precision oncology companion diagnostics, expanding market access for high-value drugs and justifying premium pricing through demonstrated clinical efficacy.
Pharmacogenomics and Drug Response Genetics Click to view more details →
Polygenic Risk Score Calculator for Medication Metabolism Optimization
A machine learning-powered analytics tool that aggregates multiple genetic variants to predict individual drug metabolism capacity and optimal therapeutic dosing ranges. Insurers and health systems deploy this solution to optimize medication efficacy, reduce treatment failures, and lower total cost of care through data-driven formulary management.
Pharmacogenomics and Drug Response Genetics Click to view more details →
Genetic Variant Database Platform for Drug Development Clinical Trials
A curated, searchable cloud-based repository of pharmacogenomic variants with clinical evidence linking genotypes to drug response outcomes and safety data. Biotech and pharmaceutical companies access this platform to accelerate trial patient stratification, improve statistical power, and accelerate regulatory approval timelines for new therapeutics.
Pharmacogenomics and Drug Response Genetics Click to view more details →
Medication Interaction Prediction Engine Using Genetic Profile Analysis
An intelligent clinical software tool that combines patient genotype data with drug metabolism information to predict dangerous drug-drug and drug-gene interactions before administration. Pharmacy benefit managers and hospital systems implement this to prevent medication errors, reduce emergency department visits, and generate significant cost savings through preventive safety.
Pharmacogenomics and Drug Response Genetics Click to view more details →
BRCA1 and BRCA2 Variant Classification
Functionally characterizing BRCA1 and BRCA2 variants using HDR assays, protein stability, and clinical data for improving variant pathogenicity classification.
Cancer Genetics and Hereditary Cancer Syndromes Click to view more details →
Lynch Syndrome MMR Gene Mutation Analysis
Developing comprehensive testing strategies including IHC, MSI testing, and gene sequencing for diagnosing Lynch syndrome in colorectal cancer families.
Cancer Genetics and Hereditary Cancer Syndromes Click to view more details →
Familial Cancer Registry and Risk Estimation
Building family cancer history registries and applying BRCAPRO and PREMM models for estimating hereditary cancer syndrome probabilities.
Cancer Genetics and Hereditary Cancer Syndromes Click to view more details →
Tumor Suppressor Gene Two-Hit Model Verification
Verifying Knudson two-hit hypothesis by detecting germline and somatic mutations in tumor suppressor genes in hereditary cancer syndrome tumors.
Cancer Genetics and Hereditary Cancer Syndromes Click to view more details →